Category: Business

(SeaPRwire) - Akkermansia has long been the holy grail of next-generation probiotics, but translating its academic promise into a commercially viable, regulatory-compliant ingredient has been a massive bottleneck. Most players struggle with the strict anaerobic requirements of the strain or get bogged down in regulatory limbo. By securing both GRAS and NDI for a human-derived strain, Thankcome isn't just launching a product; they are establishing the commercial playbook for next-gen anaerobes. The real disruptor here is the clinical validation of the gut-brain axis, which elevates this from a simple metabolic ingredient to a cornerstone of holistic wellness. Let's look at the hard facts behind this development. Thankcome Biotech, a subsidiary of Perfect Group, has officially cleared the FDA's New Dietary Ingredient (NDI) notification process for its proprietary strain, AKK PROBIO (CGMCC No.20955). This marks a major milestone as the first Akkermansia muciniphila strain of human gut origin to successfully navigate this regulatory pathway. This NDI clearance completes a highly strategic regulatory puzzle. Back in 2024, the company secured dual self-affirmed GRAS status, which allowed the strain to be used in conventional foods and beverages in both its live probiotic and pasteurized postbiotic forms. Now, with the NDI notification active, brand owners have a green light to formulate AKK PROBIO into dietary supplements across the US market. The science backing this strain is remarkably robust. Originally isolated from the gut microbiota of an elite Chinese swimming champion, the strain is supported by 18 patents, 13 peer-reviewed publications, and 7 clinical studies. One of their standout trials—a large-scale, eight-week randomized controlled study—demonstrated significant improvements in body weight, BMI, liver function, and even emotional well-being, highlighting its profound impact on the gut-brain axis. To solve the notorious stability issues of anaerobic bacteria, Thankcome developed a proprietary shell coating technology that protects the live probiotic form from oxygen. Meanwhile, their pasteurized postbiotic version uses controlled heat treatment to preserve critical membrane proteins like Amuc_1100 and secreted proteins like P9. With US distribution handled by Maypro, the stage is set for rapid commercial adoption. This regulatory breakthrough signals a broader paradigm shift in the microbiome sector. For decades, the probiotic market has relied on the same handful of Lactobacillus and Bifidobacterium strains. While these legacy strains are reliable, they represent yesterday's science. The industry is moving toward highly specialized, next-generation taxa that naturally inhabit the human gut and drive systemic health outcomes. The timing of this launch is incredibly strategic. We are living in the middle of a massive cultural shift driven by GLP-1 receptor agonists. Consumers are actively searching for natural alternatives and companion therapies that support metabolic health, satiety, and gut barrier integrity. Because Akkermansia is known to naturally stimulate endogenous GLP-1 secretion, it is positioned perfectly to capture this surging demand. The real challenge for next-gen probiotics has never been the science; it has been the bioprocessing and the regulatory compliance. Culturing strict anaerobes at an industrial scale without exposing them to lethal amounts of oxygen is incredibly difficult. Thankcome's dual-form strategy and oxygen-resistant coating technology effectively solve the manufacturing bottleneck, while their dual GRAS and NDI status removes the regulatory risk for global brands. We are about to see a wave of innovative formulations hitting the sports nutrition, metabolic health, and cognitive wellness categories. As the regulatory dust settles, the brands that move quickly to integrate these clinically backed, next-gen strains will likely dominate the next decade of the wellness market. This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - HONG KONG, June 02, 2026 -- Futu Holdings Limited ("Futu" or the "Company") (Nasdaq: FUTU), a premier technology-driven online brokerage and wealth management platform, today announced that S&P Global Ratings ("S&P") has maintained a stable outlook on its long-term rating and reaffirmed the Company's long-term issuer credit rating of "BBB-". The Futu group, comprising the Company and all its subsidiaries, holds a stand-alone credit profile of "bbb". S&P noted that Futu holds a robust market position in Hong Kong, and its continuing geographic diversification is expected to help offset the phaseout of its mainland China business over the coming two years. S&P anticipates that Futu's exceptionally strong capitalization will continue to be a fundamental credit strength. Furthermore, the Company is projected to maintain a sufficient funding profile as it broadens its business activities and geographic presence. About Futu Holdings Limited Futu Holdings Limited (Nasdaq: FUTU) is a leading technology firm that is reshaping the investment experience through fully digital financial services. Using its proprietary digital platforms, Futubull and Moomoo, the Company delivers a comprehensive suite of investment services, such as trade execution and clearing, margin financing and securities lending, and wealth management. By integrating social media tools, the Company fosters a user-centric network that connects users, investors, companies, analysts, media, and key opinion leaders. It also offers corporate services, including IPO distribution, investor relations, and ESOP solutions. For investor inquiries, please contact: Investor RelationsFutu Holdings Limitedir@futuholdings.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - TechBio startup Lucera launches, introducing decision intelligence to drug development to enhance predictability, evidence-based grounding, and efficiency The established pharmaceutical technology division of Molecular Health has been acquired by a group of life science and private equity investors to establish LuceraDelivers a robust commercial history, having successfully delivered projects for over 20 biotech, pharma, and venture capital entities globallyKey technology asset – Dataome® – offers distinct biological and medical context paired with AI-driven semantic integration and analytics. It converts data from hundreds of meticulously curated private and public sources, allowing clients to make smarter decisions, accelerate patient access to products, and lower R&D expensesEnables an early and causal grasp of new therapy development elements, such as determining suitable clinical endpoints, optimizing and simulating clinical trials, forecasting adverse effects, and spotting potential combination treatments Heidelberg, Germany, June 02, 2026 -- – Lucera GmbH, a TechBio enterprise employing proprietary technology to revolutionize pharmaceutical R&D and boost development effectiveness and efficiency via unique decision intelligence, has officially commenced operations today. The new company is backed by a consortium of institutional and private investors who purchased the pharmaceutical technology arm of Molecular Health GmbH to create this entity. Friedrich von Bohlen, PhD, takes on the role of Chief Executive Officer (CEO), while Stephan Brock, PhD, serves as Chief Technology Officer (CTO). Both possess deep experience as life sciences executives in precision medicine and drug discovery. Lucera was created to be the divide between the abundance of biomedical data and the quality of decisions in drug development. Although pharma R&D currently has unprecedented access to data, models, and AI tools, making critical choices still demands biological context, mechanistic reasoning, and evidence that is trackable, comprehensible, and defensible. To address this, Lucera utilizes Dataome®, its proprietary, semantically integrated biomedical knowledge base curated for over 15 years, to turn fragmented biomedical data into mechanistic, traceable, and decision-ready insights. This is paired with a Knowledge Graph linking biomedical entities, relationships, and evidence across various sources, modalities, and biological scales. Lucera holds exclusive rights to this technology. The company operates a validated commercial model, earning revenue from clients in pharma, biotech, CROs, management consulting, and investment firms. Friedrich von Bohlen, PhD, CEO of Lucera, remarked: “Lucera equips us with the proven technology and know-how to facilitate highly informed decision-making in biopharma R&D and life science investment. We provide clients with a comprehensive view of a new drug candidate throughout its development lifecycle—spanning from target or phenotype to clinical pathway and side effect profile. By clarifying biological rationale, patient context, evidence gaps, and development risks, Lucera aids in better assessing the probability of technical success, designing more focused cohorts, generating evidence more efficiently, and planning preclinical and clinical development more strategically. Our established track record demonstrates that this elevated standard of decision quality empowers drug developers and investors to achieve greater success in program prioritization, planning, and resource allocation.” Lucera comprises an interdisciplinary team of 25 professionals who transitioned from Molecular Health, bringing rich expertise in biomedical knowledge engineering, AI, computational biology, translational science, real-world evidence, drug development intelligence, and consulting. Headquartered in Heidelberg, Germany, the company serves a global clientele. About Lucera GmbHLucera is a technology firm headquartered in Heidelberg, Germany, dedicated to bolstering decision intelligence by leveraging advanced data integration and artificial intelligence within pharmaceutical research and development. The company is built upon a solid foundation of proprietary data, expert curation, and sophisticated analytics, featuring a semantically integrated knowledge base—Dataome®—refined over more than 15 years.Lucera’s platform tackles critical questions regarding target and mechanism validation, indication prioritization, biomarker and patient stratification, translational evidence strategy, clinical and real-world evidence interpretation, trial design, clinical trial simulation, and asset and portfolio due diligence. These capabilities rely on Dataome®’s robust medical and biological context and quality.The company assists pharmaceutical and biotechnology organizations, as well as institutional and corporate investors, in pinpointing, evaluating, and advancing high-potential programs. By blending customized AI solutions with accessible Software-as-a-Service (SaaS), Lucera drives improved decision quality, heightened efficiency, and increased asset value. About Dataome®Central to Lucera’s offerings is Dataome®, a proprietary technology that integrates and contextualizes biomedical, molecular, phenotypic, and drug data. It converts fragmented biomedical evidence into mechanistic, traceable, and decision-ready insights. Dataome® synthesizes hundreds of public and private biomedical sources into a structured, AI-ready knowledge layer. It is pan-disease and multi-modal, covering a wide spectrum including drugs, active pharmaceutical ingredients, targets, genes, variants, pathways, molecular entities, phenotypes, clinical evidence, real-world data, and disease biology. Its semantic architecture ensures AI outputs are biologically grounded, explainable, and traceable to their supporting evidence.The Knowledge Graph underlying Dataome® empowers Lucera to transcend isolated data points by linking evidence into biological context. This enables the generation of insights that are predictive, interpretable, reviewable, and relevant to decision-making.Lucera merges Dataome® and its Knowledge Graph with digital molecular twins, mechanistic models, multi-omics interpretation, real-world evidence integration, representation learning, embeddings, and orthogonal evidence convergence. Collectively, these features enable Lucera to determine if independent evidence layers support, contradict, or refine a biological hypothesis—and to convert these evaluations into actionable decision intelligence. Lucera GmbH Friedrich von Bohlen, PhDCEO lucera@mc-services.euMedia RelationsKatja Arnold, Eva BauerPhone: +49-89-210 2280In the U.S.: Laurie DoylePhone: +1 339 832 0752lucera@mc-services.eu This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - QINHUANGDAO, China, June 01, 2026 -- With the summer travel season now in full swing, Qinhuangdao, Hebei Province, is experiencing a notable rise in international tourism. Data from Trip.com, the overseas platform of Ctrip, indicates that between January 1 and May 25, 2026, international interest in the Shanhaiguan scenic area surged, with page views jumping 241.8% year-on-year and booking conversions increasing by 43.25% compared to the same period last year. This reflects a clear growth in both global visibility and travel demand. Throughout this year, Qinhuangdao has been actively enhancing its international service infrastructure to provide overseas guests with a seamless, accessible, and deeply engaging travel experience. A Media Snippet accompanying this announcement is available by clicking on this link. Recently, tourist sites across Shanhaiguan have integrated smart translation technology capable of handling over 80 languages and 200 dialects, facilitating hands-free, real-time communication. Furthermore, the introduction of bilingual audio guides and international self-service ticketing kiosks has created a streamlined service ecosystem for ticketing, entry, and guided tours. These scenic areas have also refined their multilingual signage and other international service touchpoints. Whether exploring the historic "First Pass Under Heaven" or visiting the iconic Laolongtou, where the Great Wall meets the sea, international travelers can now enjoy barrier-free information access and a more immersive visit. These improvements highlight Qinhuangdao’s broader commitment to internationalizing its tourism sector. By capitalizing on its Great Wall heritage and coastal geography, the city has curated a diverse array of attractions, such as the Great Wall Light Show, the Port Industrial Tourism Zone, and the Aranya art district. From historic landmarks and seaside vistas to contemporary art and ecological activities like birdwatching and wellness retreats, the city offers a variety of experiences tailored to the diverse tastes of global and domestic travelers. Qinhuangdao features a unique ecological landscape in northern China, characterized by a harmonious blend of mountains, sea, rivers, lakes, and wetlands. During the early summer months, the city’s lush flower fields and pleasant, high-quality air make it a premier summer retreat and wellness destination for the Beijing-Tianjin-Hebei region. By aligning its service standards with global benchmarks, this coastal city is embracing an increasingly open and inclusive approach, inviting visitors from around the world to enjoy its distinctive mountain and seaside beauty. Source: Publicity Department of the Qinhuangdao Municipal Committee CONTACT: Contact person: Mr. Zhang, Tel: 86-10-63074558 This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - WUXI, China, June 1, 2026 — HUHUTECH International Group Inc. (NASDAQ: HUHU) (“HUHU” or the “Company”), a global supplier of high-purity process systems as well as factory facility management and monitoring solutions for semiconductor manufacturers and industrial clients around the world, today shared further details about its business operations, customer track record, and the recently disclosed €13.9 million contract secured by its German subsidiary. As previously reported on May 27, 2026, HUHU Technologies Deutschland GmbH, the Company’s German subsidiary, obtained seven purchase orders totaling roughly €13.9 million (equivalent to about US$15.0 million) from a leading European advanced-node semiconductor wafer fabrication operator that supports the global AI and high-performance computing supply chain. Key details of the European semiconductor contract include: Seven purchase orders with a combined value of around €13.9 million (or roughly US$15.0 million);Two primary purchase orders worth approximately €10.9 million and €1.8 million each;Initial deposits of about €635,000 (or roughly US$740,000) have already been received by the Company;The deposits are anticipated to appear in the Company’s upcoming interim financial reports;Around 20% of the total contract value—equivalent to roughly €2.8 million (or US$3.0 million)—is expected to be recognized in fiscal year 2026;The remaining amount is projected to be recognized in fiscal year 2027, pending project delivery, customer approval, and compliance with relevant revenue recognition standards; andA contract-related announcement was submitted on Form 6-K to the U.S. Securities and Exchange Commission. HUHU delivers high-purity process systems and engineering solutions that support advanced semiconductor manufacturing facilities, with operations in China, the United States, Germany, Singapore, and Japan. The Company has built a history of serving top memory semiconductor manufacturers and advanced manufacturing clients in China. Internationally, it has also secured orders from customers including a global provider of DRAM and NAND memory solutions. “Although some customer identities and project specifics are bound by confidentiality agreements typical in the semiconductor industry, we think offering more clarity on the contract structure, deposits received, and expected revenue recognition is beneficial for investors,” stated Mr. Yujun Xiao, Chief Executive Officer of HUHUTECH. “This project demonstrates HUHU’s continued involvement in advanced semiconductor infrastructure initiatives across various global markets.” About HUHUTECH International Group Inc. HUHUTECH International Group Inc. is a global provider of high-purity process systems, factory facility management, and monitoring systems for semiconductor manufacturers and industrial clients across the globe. Via its subsidiaries in China, Japan, the United States, Germany, and Singapore, the Company designs and supplies tailored high-purity process systems (HPS) and factory management and control systems (FMCS) that support essential manufacturing infrastructure in global semiconductor and industrial sectors. Safe Harbor Statement Some statements in this announcement are forward-looking statements as defined under the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other U.S. federal securities laws. All statements in this announcement that are not historical facts qualify as forward-looking statements. These include, but are not limited to, explicit or implicit statements about the Company’s future expectations, hopes, beliefs, intentions, or strategies. Forward-looking statements are not historical facts nor guarantees of future performance; instead, they are based solely on the Company’s current beliefs, expectations, and assumptions about its future business, plans, strategies, projections, expected events and trends, the economy, and other future conditions. Since forward-looking statements pertain to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are hard to predict, many of which are beyond the Company’s control. You can recognize forward-looking statements by their non-historical nature, especially those using terms like “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” — or their negatives or similar expressions. Forward-looking statements are based on current expectations and assumptions that, while deemed reasonable, are inherently uncertain. New risks and uncertainties may arise over time, and it is impossible to predict all of them. The Company’s actual results may vary significantly from those suggested in the forward-looking statements. Therefore, you should not place reliance on any of these forward-looking statements. Key factors that could lead to material differences between actual results and those indicated in the forward-looking statements include the risks and uncertainties outlined in the Company’s annual report on Form 20-F for the fiscal year ending December 31, 2025, filed with the U.S. Securities and Exchange Commission (the “Commission”) on April 28, 2026, as well as the Company’s other filings with the Commission. Unless required by law, the Company does not undertake any obligation to publicly update any forward-looking statement (whether written or oral) made from time to time, whether due to new information, future developments, or any other reason. Company Contact Email: ir@huhutech.com Website: www.huhutech.com Investor Relations Contact Matthew Abenante, IRC President Strategic Investor Relations LLC Phone: +1 (347) 947-2093 Email: matthew@strategic-ir.com Web: www.strategic-ir.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - BEIJING, June 01, 2026 -- Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a provider of generative AI-driven technology solutions specializing in virtual content production and the development of 3D digital assets, announced today that it has submitted an application to join the Snowflake Partner Network (SPN), a component of Snowflake’s global AI Data Cloud ecosystem. This move underscores Global Mofy’s persistent commitment to broadening its worldwide technology ecosystem and reinforcing its digital content data competencies. With the rising need for AI-enabled content generation, premium digital assets, and scalable data infrastructure, Global Mofy is dedicated to constructing solutions that are more efficient, secure, and intelligent for clients in industries such as film, TV, gaming, digital cultural tourism, and other digital content fields. Global Mofy has established expertise in virtual content production, the creation of high-precision 3D digital assets, and generative AI technology. By integrating its industry resources, production background, and digital asset strengths with top-tier cloud and data ecosystems, the Company seeks to significantly improve the handling, application, and monetization of digital content data. As part of its wider ecosystem strategy, Global Mofy intends to investigate prospects for creating integrated digital content data solutions. These solutions are intended to facilitate data governance, smart asset management, AI-supported production workflows, and scalable implementation across various commercial use cases. “This initiative represents a further advancement in Global Mofy’s global ecosystem strategy,” stated Wenjun Jiang, CTO of Global Mofy. “We are convinced that the future landscape of digital content will be progressively shaped by intelligent data infrastructure, superior digital assets, and AI-driven production capabilities. Global Mofy remains committed to bolstering its technology ecosystem and providing more efficient, secure, and intelligent digital content solutions to a global clientele.” About Global Mofy AI LimitedGlobal Mofy AI Limited (Nasdaq: GMM) operates as a generative AI-driven technology solutions provider focused on virtual content production and the development of digital assets for the digital content sector. Leveraging its proprietary “Mofy Lab” technology platform, which incorporates interactive 3D and artificial intelligence (“AI”) technologies, the Company generates high-definition virtual 3D representations of a vast array of real-world objects, spanning characters, items, scenes, and beyond. These digital assets are applicable across various uses, such as films, TV shows, AR/VR, animation, marketing, gaming, and others. Global Mofy Metaverse stands as a premier digital asset bank in China, housing a collection of over 150,000 high-precision 3D digital assets. Further details can be found at www.globalmofy.ai or ir.globalmofy.cn. Forward-Looking StatementThis press release includes forward-looking statements. Such statements pertain to plans, objectives, goals, strategies, future occurrences or performance, underlying assumptions, and other non-historical statements. When the Company employs terms like “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” or similar phrases not strictly related to historical facts, it is issuing forward-looking statements. These statements do not guarantee future performance and are subject to risks and uncertainties that could cause actual outcomes to vary significantly from the Company’s expectations outlined in the forward-looking statements. These statements face uncertainties and risks, including but not limited to market condition fluctuations, our capacity to adapt to new technologies and evolving market demands, and our business’s competitive landscape. These elements, among others, might cause our actual results to diverge materially from any forward-looking statement. Consequently, investors are advised against placing undue reliance on forward-looking statements within this press release. Further factors are detailed in the Company’s SEC filings, accessible at www.sec.gov. The Company assumes no duty to publicly update these forward-looking statements to account for events or developments occurring after this date. For more information, please contact:Global Mofy AI Ltd.Investor Relations Departmentir@mof-vfx.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - Singapore, June 01, 2026 -- EUDA Health Holdings Limited (“EUDA” and the “Company”), a Singapore-based non-invasive healthcare provider operating in Asia with a focus on Singapore, Malaysia, and China, received written notification (the “MVLS Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on April 23, 2026. The notice indicated that the Company had not maintained a Minimum Market Value of Listed Securities (“MVLS”) of $35 million for the preceding 32 consecutive business days, as required by Nasdaq Listing Rule 5550(b)(2). On May 28, 2026, the Company received a written notice from Nasdaq stating that the Company’s Market Value of Listed Securities had been $35 million or greater for ten consecutive business days, from May 13 to May 27, 2026. Consequently, the Company has regained compliance with the MVLS requirement for continued listing on the Nasdaq Capital Market. About EUDA Health Holdings Limited EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based non-invasive healthcare provider in Asia, with operations concentrated in Singapore, Malaysia, and China. The Company aspires to be a market leader in non-invasive and preventive healthcare, with a strategic emphasis on the rapidly expanding longevity sector. Our mission is to address the evolving healthcare needs of approximately 1.8 billion people across the region, who are experiencing significant demographic shifts, with over 30% of the population aging rapidly. EUDA believes that by providing innovative, accessible, and science-backed health solutions, it is well-positioned to lead the transformation of regional healthcare from a reactive medical treatment model to a proactive, longevity-focused approach. EUDA also operates a property management business based in Singapore. Forward-Looking Statements Certain statements within this press release that are not historical facts are considered “forward-looking statements” under Section 21E of the Securities Exchange Act of 1934, as amended. Any statements that express expectations or other characterizations of future events, circumstances, or results are forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that could cause the company's actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by such statements. These factors may include, but are not limited to, factors related to the Company’s anticipated growth strategies, future business development, its ability to develop new products, expand into other related industries or markets, and other information detailed from time to time in filings and future filings with the United States Securities and Exchange Commission. The views expressed are those of management and are based on currently available information. Estimates and projections contained herein have been prepared by management and involve significant elements of subjective judgment and analysis, based on certain assumptions. No representation or warranty, express or implied, is made as to the accuracy or completeness of the information contained in this document, and nothing contained herein should be relied upon as a promise or representation regarding the past or the future. You are cautioned not to place undue reliance on these forward-looking statements. This press release is intended solely for informational purposes and should not be construed as an offer to sell or the solicitation of an offer to buy the Company’s stock. This press release is based on publicly available information, as well as other information from sources that management believes to be reliable, but the Company does not guarantee its accuracy nor does it purport to be complete. Opinions expressed herein are those of management as of the date of publication and are subject to change without notice. Except for the Company’s ongoing obligations to disclose material information under the federal securities laws, the Company undertakes no obligation to release any revisions to any forward-looking statements, to report events, or to report the occurrence of unanticipated events. For investor and media inquiries, please contact: Christensen Advisory Christian ArnellPhone: +852 2117 0861Email: christian.arnell@christensencomms.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - SINGAPORE, June 1, 2026 — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-headquartered non-invasive healthcare provider operating across Asia with a focus on Singapore, Malaysia, and China, today announced the expansion of its Helixé product line through the launch of the Regenixé iPSC-Derived Skin Stem Cell Secretome Mask (“Regenixé Mask”), a beauty product created by Chemokine Pte Ltd (“Chemokine”). EUDA possesses exclusive global distribution rights for Helixé products—including, but not limited to, a next-gen immune health supplement—from Chemokine, a Singapore-based biotech firm specializing in molecular supplements and gene-modulating formulas. The Regenixé Mask is crafted using iPSC-derived skin stem cell secretome technology and cellulose mask technology, both designed to enhance skin hydration, brightening, and overall rejuvenation. EUDA believes secretome-based skincare items are part of a rapidly growing segment in the premium beauty and wellness industry. Per Mordor Intelligence’s Face Mask Market Report, the global face mask market is projected to hit around US$7.95 billion in 2026 and is expected to rise to approximately US$9.08 billion by 2031, fueled by increasing consumer demand for skincare, beauty, and wellness products. The Asia-Pacific region continues to be one of the largest markets for facial masks and skincare items, driven by demand from China, South Korea, Japan, and Southeast Asia. EUDA plans to utilize its existing distribution networks and regional wellness partnerships in Malaysia and China to boost sales and distribution of the Regenixé Mask, as well as expand the wider Helixé product line throughout the Asia-Pacific region. About EUDA Health Holdings Limited EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based non-invasive healthcare provider serving Asia, with key markets in Singapore, Malaysia, and China. The Company aspires to become a market leader in non-invasive and preventive healthcare, with a strategic emphasis on the rapidly expanding longevity sector. Our mission is to meet the changing healthcare needs of over 1.8 billion people across the region—where significant demographic shifts are occurring as more than 30% of the population ages quickly. EUDA believes that by providing innovative, accessible, and science-driven health solutions, it is well-positioned to lead the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. Additionally, EUDA operates a property management business based in Singapore. Forward-Looking Statements Certain statements in this press release that are not historical facts qualify as “forward-looking statements” under Section 21E of the Securities Exchange Act of 1934, as amended. Any statements referring to expectations or other descriptions of future events, circumstances, or outcomes are forward-looking statements. These forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that could cause the company’s actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by such statements. These factors may include—but are not limited to—those related to the Company’s expected growth strategies, future business expansion, ability to develop new products, enter related industries or markets, and other details included in filings and future submissions to the U.S. Securities and Exchange Commission. The views expressed are those of management and are based on currently available data. Estimates and projections in this document were prepared by management and involve substantial subjective judgment and analysis, based on specific assumptions. No representation or warranty (express or implied) is made regarding the accuracy or completeness of the information in this document, and nothing herein should be relied upon as a promise or representation, whether regarding past or future events. You are advised not to place excessive reliance on these forward-looking statements. This press release is for informational purposes only and should not be interpreted as an offer to sell or a solicitation of an offer to purchase the Company’s stock. The release is based on public information and other data from sources management deems reliable, but the Company does not guarantee its accuracy or completeness. The opinions expressed here are those of management as of the publication date and are subject to change without prior notice. Unless required by federal securities laws to disclose material information, the Company has no obligation to issue revisions to forward-looking statements, report events, or notify of unanticipated occurrences. Christensen AdvisoryChristian ArnellPhone: + 852 9040 0621Email: christian.arnell@christensencomms.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - BEIJING, June 01, 2026 -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today reported the continuation of its share repurchase initiative, having spent over RMB40.6 million to acquire 879,212 ordinary shares on May 29, 2026. This latest transaction brings the Company's year-to-date share repurchases in 2026 to nearly RMB1.6 billion. This action highlights the Company's sustained dedication to enhancing shareholder value. On March 18, 2026, the Board of Directors approved modifications to the existing share repurchase program, raising the total authorized amount for repurchasing up to US$400 million of the Company's shares (including ADSs). This extended program runs through August 28, 2027, reflecting optimism regarding the Company's future growth trajectory. The Company also announced on March 18, 2026, that for each of the three years commencing in 2026, it intends to allocate a minimum of 50% of the Company’s adjusted net income (a non-GAAP financial measure) from the preceding fiscal year towards dividend distributions and share repurchases. The Board reserves the right to modify its share repurchase and dividend plans at its discretion, considering factors such as financial performance, capital needs, market conditions, and other relevant considerations. The Company will provide timely updates to its shareholders as appropriate, in compliance with applicable laws and regulations. CONTACT: CONTACT: PIACENTE FINANCIAL COMMUNICATIONS kanzhun@tpg-ir.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - BEIJING, China, June 01, 2026 -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a prominent player in China's new energy vehicle market, today announced its delivery figures for May 2026. The Company delivered 33,350 vehicles during the month. As of May 31, 2026, Li Auto's cumulative deliveries have reached a total of 1,702,792. Since March of this year, monthly deliveries for the Li i6 model have consistently surpassed 20,000 units. In May, the Company introduced and began deliveries of the all-new Li L9, marking the commencement of a new product update cycle for the Li L series. Within two weeks of its release, the all-new Li L9 Livis garnered over 10,000 orders. Looking ahead to June, Li Auto is scheduled to host a dedicated technology event to provide in-depth insights into its advancements in in-cabin interaction, foundation models, assisted driving, system agents, and in-house chips. This will be followed by the late-June launch of the all-new Li L8, a five-seat flagship SUV. As of May 31, 2026, the Company operated 498 retail stores across 160 cities. Additionally, 543 servicing centers and Li Auto-authorized servicing shops were operational in 222 cities. The Company also maintained 4,088 super charging stations in operation, featuring 22,563 charging stalls throughout China. About Li Auto Inc. Li Auto Inc. stands as a leader in China's new energy vehicle market, specializing in the design, development, manufacturing, and sale of premium smart electric vehicles. The Company's mission is to "Be Proactive, Change the World." Through continuous innovation in product, technology, and business models, Li Auto aims to provide families with safe, convenient, and comfortable products and services. The Company is recognized as a pioneer in the successful commercialization of extended-range electric vehicles in China. While actively progressing with this technological approach, Li Auto is also developing platforms for battery electric vehicles concurrently. The Company utilizes technology to deliver value to its users, focusing its in-house development efforts on proprietary range extension systems, advanced electric vehicle technologies, and intelligent vehicle solutions. Li Auto commenced volume production in November 2019. Its current vehicle lineup includes a high-tech flagship family MPV, four Li L series extended-range electric SUVs, and two Li i series battery electric SUVs. The Company plans to further expand its product offerings to cater to a wider customer base. For more information, please visit: https://ir.lixiang.com. Safe Harbor Statement This press release contains statements that may be considered “forward-looking” under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can often be identified by terms such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “targets,” “likely to,” “challenges,” and similar expressions. Li Auto may also issue written or oral forward-looking statements in its periodic filings with the U.S. Securities and Exchange Commission (the “SEC”) and The Stock Exchange of Hong Kong Limited (the “HKEX”), in its annual reports to shareholders, in press releases and other written communications, and in oral statements made by its executives, directors, or employees to third parties. Statements that are not historical facts, including statements about Li Auto’s beliefs, plans, and expectations, are considered forward-looking statements. Forward-looking statements inherently involve risks and uncertainties. Various factors could cause actual results to differ materially from those projected in any forward-looking statement, including, but not limited to, the following: Li Auto’s strategies, future business development, and financial condition and results of operations; Li Auto’s limited operating history; risks associated with extended-range electric vehicles and high-power charging battery electric vehicles; Li Auto’s ability to develop, manufacture, and deliver high-quality vehicles that appeal to customers; Li Auto’s ability to achieve positive cash flow and profitability; product defects or any other failures of vehicles to perform as expected; Li Auto’s ability to compete effectively; Li Auto’s ability to build its brand and withstand negative publicity; cancellation of orders for Li Auto’s vehicles; Li Auto’s ability to develop new vehicles; and changes in consumer demand and government incentives, subsidies, or other favorable government policies. Further details regarding these and other risks are included in Li Auto’s filings with the SEC and the HKEX. All information provided in this press release is current as of the date of this press release, and Li Auto undertakes no obligation to update any forward-looking statement, except as required by applicable law. For investor and media inquiries, please contact: Li Auto Inc.Investor RelationsEmail: ir@lixiang.com Christensen AdvisoryRoger HuTel: +86-10-5900-1548Email: Li@christensencomms.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - BEIJING, May 31, 2026 -- This year marks the 70th anniversary of China-Africa relations. CGTN has published an article emphasizing Africa's priority role in China's overall foreign policy, while detailing how the China-Africa partnership has been established and strengthened over decades. The article also examines how deeper cooperation in recent years has helped amplify the voice and representation of the Global South, and contributed to fostering a more balanced and democratic international order. As Chinese President Xi Jinping and Egyptian President Abdel-Fattah al-Sisi exchanged congratulatory messages on Saturday to commemorate the 70th anniversary of China-Egypt ties, the occasion also highlighted a broader milestone: seven decades of China-Africa relations. Xi noted that over the past 70 years, China-Egypt relations have become a model of amity, solidarity, and cooperation among developing countries, as well as a benchmark for collaboration between China and Arab states and between China and Africa. Today, China-Africa relations have evolved from a friendship forged in shared struggles into a dynamic partnership dedicated to development, modernization, and the rise of the Global South. From solidarity to strategic partnership The foundations of China-Africa friendship were laid during a period of profound political transformation. From the 1950s to the 1970s, China firmly supported African countries in their struggles for national independence and liberation. African nations, in turn, played a decisive role in restoring the lawful seat of the People's Republic of China at the United Nations in 1971. Of the 76 votes cast in favor of the resolution, 26 came from African countries – laying a strong foundation for China-Africa mutual trust. Earlier this year, Chinese Foreign Minister Wang Yi visited Africa, continuing a 36-year tradition of making the continent the destination of China's foreign minister's first overseas trip each year, underscoring the importance of China-Africa relations. Over the past two decades, China-Africa cooperation has expanded rapidly. The establishment of the Forum on China-Africa Cooperation (FOCAC) in 2000 provided an institutional framework for cooperation, while China's Africa policy of sincerity, real results, amity, and good faith further guided bilateral relations. In 2015, the two sides elevated their ties to a comprehensive strategic cooperative partnership and launched the "Ten Cooperation Plans," setting a strong foundation for rapid modernization across the African continent. At the 2024 FOCAC summit, China and Africa further upgraded their relationship to an all-weather community with a shared future for the new era. China also expanded duty-free access from 33 African countries to all 53 African countries with diplomatic ties by 2025, becoming the first major economy to grant unilateral zero-tariff treatment across all product categories to every African country with which it has diplomatic relations. Humphrey Moshi, a prominent Tanzanian economist, described China-Africa cooperation as a significant example of Global South solidarity. He said such solidarity helps transform developing countries from "passive participants" into "active shapers" of international rules. Advancing modernization through practical cooperation While political trust forms the foundation of China-Africa relations, economic cooperation has become both the stabilizer and growth engine of the partnership. According to data released by China's General Administration of Customs, China-Africa trade reached a record $348 billion in 2025, up 17.7% from the previous year, with China remaining Africa's largest trading partner for the 17th consecutive year. The momentum has continued into 2026. In the first quarter alone, China's trade with the African countries totaled 646.56 billion yuan ($92.2 billion), a year-on-year increase of 23.7%. At the same time, the Belt and Road Initiative has reshaped connectivity across the continent by upgrading the railway system with projects such as the Tazara Railway and the Mombasa-Nairobi Standard Gauge Railway, which are flagship projects that set examples for high-quality Belt and Road cooperation between China and Africa. According to China's Foreign Ministry, China has signed debt-relief agreements or reached debt-relief understandings with 19 African countries as of 2023, making it the largest contributor to debt-service suspension efforts under the G20 framework. Meanwhile, China has trained tens of thousands of African professionals through scholarships, vocational training, and educational exchange programs. As of June 2025, China has established 17 Luban Workshops across 15 African countries, while the China-Africa university cooperation plan, a higher education initiative pairing Chinese universities with African institutions, has connected 114 higher education institutions. Paul Frimpong, executive director and senior research fellow of the Africa-China Centre for Policy & Advisory, said China's contribution to Africa's development is increasingly visible. "China's sharing of knowledge, skills, and experience in sectors such as manufacturing and green energy is having a profound impact on Africa's journey toward modernization and self-reliance," he added. https://news.cgtn.com/news/2026-05-30/China-Africa-ties-at-70-Path-to-a-shared-dream-of-modernization-1NzbT7rDWhy/p.html CONTACT: CGTN Digital cgtn@cgtn.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.